George Frangeskides, Exec-Chair at Alba Mineral Resources, discusses grades at the Clogau Gold Mine. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I would be happy going to buy a Fiat Tipo estate to be honest
Hi All
The main issue I had with the video was the way too much uuurmmming and aarrhhing. This would have been a planned video presentation with SAR providing the questions to the host and therefore should have been a slick, confidence boosting and clear message delivery......IMHO we saw none of that. What adds more concern is that they could have done (maybe did) numerous takes. I know from personal experience when being asked to do these types of media messaging, the videographer says “don’t worry we’ll edit that out” etc etc.
To be frank, it was a poor Comms/PR exercise that hasn’t delivered the required message and as per SAR’s modus operandi it raises more questions than provided answers.
Rant over and keeping the faith........come on Tim!!
GLA
colbaltblue, good afternoon. Its good points you make and to be clear , I'm not expecting Tim to "spiv" himself up to win a beauty contest, however I am expecting him to be well prepared and to give the appearance of somebody trying to sell the merits of a "billion dollar" product. When you go into the showroom to buy your Aston Martin after SAR has come right you would expect to be greeted by somebody presentable who knows there product and has a plan to get you to part with your £100K, that's all I'm asking.
I have three current shares where the CEO's are smart, articulate and reasonably slick. Unfortunately, the share performance of the Companies they lead does not match the expensive suits and the powerpoint presentations! In all three cases, there has been no offer to defer or reduce remuneration packages pending an improvement in the business unlike Tim. He is a boffin. They are often a little bit on the "spectrum" and don't always present themselves that well. We all know people like that and perhaps he knows things that allow him to be somewhat "relaxed"! Please avoid this becoming a beauty competition.
There's some very good and valid points being raised in the posts this morning. For me the key one is we must have a plan and at the moment it almost appears TM is like a rudderless ship, the ship goes in whichever direction the wind blows from.
If, and I say if, we are looking to address billion dollar markets in multiple indications of both autoimmune and cancer then surely there has to be a detailed plan with tollgates to measure our progress. The rather "fluffy" interviews, presentations and RNS's just don't cut it Tim and it's time you were brought to task by either Parker or the NED's to sharpen up your act in all communications. Please as a start put on a shirt and tie for next weeks presentation, maybe go into the office and put backdrop behind you with a relevant marketing message or company mission statement upon it, don't as I suspect you will, present yourself as an incoherent ragamuffin sat at his dining room table. Wake up fella it's time to shine up..
RMM
You've actually hit the nail on the head. The science is (as far as we know) top notch.
But Tim's lack of urgency is a concern, he 'might apply for a covid-19 grant, but might use some of the money recently raised' as he said a day or 2 ago shows a clear lack of direction, and sadly masses of indecisiveness.
The financial drain of the NED's have returned NOTHING to us in the last 18+ months now, so he needs to explain what they are on board for. Because at present, it seems to be just along for the ride and to receive a wage every month. I said this many times before, if our NED's worked at a larger company, not even a multinational pharma, they'd of been being grilled after 2 months of delivering nothing. After 4 or 5 months, they'd be out the door with a tarnished reputation.
Sar (we) of all people can't afford to pay extra bodies, especially if we keep having to raise to cover 'overheads and operating costs'
People are getting fed up with all of the 'we might', 'we hope', 'we think we might' etc etc. Its wearing thin.
Ahfam I believe the same as you or I did. The RNS and interview made it sound like we had paused development and now we're picking it back up? I was thinking if we we're in negotiations then we probably would pause the preclinical development to save money but if either party walks away then we lost that time. It makes sense, and Tim eluded to the fact that we wouldn't pick the indications the other company would and they would develop the compound as they see fit. Covid has changed that. I do still think Covid is a bolt on though. A bit like a loss leader in a supermarket. The compounds ultimate development and use will be in the wider autoimmune arena.
Hi Potnak
I to had another top up at .59. I completely agree that it is as if in the last 12 months nothing has happened with our TYK2s. In RNSs from last year we were meant to be heading to the clinical by H2 with at least one if not both candidates. They made a statement about a robust volume supply chain for 1801 and they were working on 1802. I can appreciate that covid put a spanner in the works with general lockdowns but the clinical plan and targeted indications could have been finalised. In his RNS last year, TM used words such as ‘refine the clinical plan’ which alluded me to think it needed tweaking only, now it seems it has not been written yet, never mind reviewed, refined and approved ready to submit for trial approval - his video gave me the sense of not much decision making having been done.
Tim - What have the NEDs been doing? After all we are paying for them.
Like I said earlier this week, we need to see a published operating plan that we as shareholders can measure the boards/outsourced resources performance against. Time to stand and be counted and provide transparency to your shareholders.
GLA
Good replies guys. My take on the 'significant value' was that Tim was expecting 737 milestones with the possibility that TYK2 might get licenced. The fact that Sierra/NG played games put paid to the most obvious return and the TYK2 licence has been complicated by not reaching a MTD and latterly Covid. For me the next 3 months are crucial if my faith is to be maintained. So far I've seen nothing tangible to unseat my view of the science but the lack of urgency worries me. They may be working hard but as I used to point out to my colleagues, working hard and putting in long hours does not mean you are doing your job. Lets have some results.
Potnak, I believe Tim et all at Sareum really were about to deliver that value but then covid19 happened and changed the goalposts for the better of course. I think th e deal was in negoatiation but with the covid issue it increased the value of tyk2 auto-immune and now there are more interested parties. In my opinion I still think pfizer will go for the auto-immune before we take it into clinic it's got blockbuster fast-track written all over it.
I'm probably known on here for giving SAR the benefit of doubt. I'm very rarely negative about them. I'm ok with the raise and the reasons that were initially given in the first RNS. But in the subsequent RNS and interview. SAR and Tim seems to have completely disregard the last 12 months and it feels like we haven't progressed at all. I'm sure when Tim said value in 12 months he meant it and was confident about meeting the deadline so something has changed. I did buy 200k more shares @0.59 to protect me from the dilution but it was peanuts compared to some holders. Last year, I set myself a deadline of the end of 2020 where I will reevaluate my holding. I'm hoping Tim comes up with something much sooner than that. I have a feeling that he will and it won't be far off. Let me be clear though. I will hold for as long as it takes but they have to give me something to hold for. This has to be the last time they come to us for money. FWIW. I do think this is the last raise us LTH will see.
Good honest post RMM. As I mentioned the other day on here, I have a substantial holding and have held for over 10 years. I would never put another penny into Sareum unless there is a bit more honesty from Tim and Co. I really thought Tim had a plan to deliver significant value by now as he actually stated as much. Without news I can only see this slipping back. GLA